Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism

被引:351
|
作者
Hauser, David N. [1 ,2 ]
Hastings, Teresa G. [3 ,4 ,5 ]
机构
[1] NIA, Cell Biol & Gene Express Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA
[2] Brown Univ, NIH, Grad Partnership Program, Dept Neurosci, Providence, RI 02912 USA
[3] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA
[4] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA
[5] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA
关键词
Parkinson's disease; Mitochondria; Oxidative stress; Dopamine oxidation; RAT-BRAIN MITOCHONDRIA; COMPLEX-I DEFICIENCY; RESOLUTION CRYSTAL-STRUCTURE; CYSTEINE-SULFINIC ACID; SUBSTANTIA-NIGRA; ALPHA-SYNUCLEIN; DOPAMINERGIC-NEURONS; DJ-1-DEFICIENT MICE; DNA DELETIONS; FAMILIAL PARKINSONISM;
D O I
10.1016/j.nbd.2012.10.011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The pathogenic mechanisms that underlie Parkinson's disease remain unknown. Here, we review evidence from both sporadic and genetic forms of Parkinson's disease that implicate both mitochondria and oxidative stress as central players in disease pathogenesis. A systemic deficiency in complex I of the mitochondrial electron transport chain is evident in many patients with the disease. Oxidative stress caused by reactive metabolites of dopamine and alterations in the levels of iron and glutathione in the substantia nigra accompany this mitochondrial dysfunction. Recent evidence from studies on the genetic forms of parkinsonism with particular stress on DJ-1, parkin, and PINK-1 also suggest the involvement of mitochondria and oxidative stress. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 50 条
  • [31] Mitochondrial dysfunction in Parkinson's disease
    A H V Schapira
    Cell Death & Differentiation, 2007, 14 : 1261 - 1266
  • [32] Mitochondrial dysfunction in Parkinson's disease
    Greenamyre, JT
    MacKenzie, G
    Peng, TI
    Stephans, SE
    MITOCHONDRIA AND CELL DEATH, 1999, 66 : 85 - 97
  • [33] Mitochondrial dysfunction in Parkinson's disease
    Hattori, Nobutaka
    Sato, Shigeto
    JOURNAL OF NEURAL TRANSMISSION, 2024, 131 (12) : 1415 - 1428
  • [34] Mitochondrial dysfunction in Parkinson's disease
    Mizuno, Y
    Yoshino, H
    Ikebe, S
    Hattori, N
    Kobayashi, T
    Shimoda-Matsubayashi, S
    Matsumine, H
    Kondo, T
    ANNALS OF NEUROLOGY, 1998, 44 (03) : S99 - S109
  • [35] Mitochondrial dysfunction in Parkinson's disease
    Winklhofer, Konstanze F.
    Haass, Christian
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2010, 1802 (01): : 29 - 44
  • [36] Autonomic dysfunction in Parkinson's disease and vascular parkinsonism
    Murata, Y
    Harada, T
    Ishizaki, F
    Izumi, Y
    Nakamura, S
    ACTA NEUROLOGICA SCANDINAVICA, 1997, 96 (06): : 359 - 365
  • [37] Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease
    Imbriani, Paola
    Martella, Giuseppina
    Bonsi, Paola
    Pisani, Antonio
    NEUROBIOLOGY OF DISEASE, 2022, 173
  • [38] Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations
    Puschmann, Andreas
    PARKINSONISM & RELATED DISORDERS, 2013, 19 (04) : 407 - 415
  • [39] L-Methionine Protects against Oxidative Stress and Mitochondrial Dysfunction in an In Vitro Model of Parkinson's Disease
    Catanesi, Mariano
    Brandolini, Laura
    d'Angelo, Michele
    Benedetti, Elisabetta
    Tupone, Maria Grazia
    Alfonsetti, Margherita
    Cabri, Enrico
    Iaconis, Daniela
    Fratelli, Maddalena
    Cimini, Annamaria
    Castelli, Vanessa
    Allegretti, Marcello
    ANTIOXIDANTS, 2021, 10 (09)
  • [40] Oxidative stress and mitochondrial dysfunction are the underlying events of dopaminergic neurodegeneration in homocysteine rat model of Parkinson's disease
    Bhattacharjee, Nivedita
    Borah, Anupom
    NEUROCHEMISTRY INTERNATIONAL, 2016, 101 : 48 - 55